105 related articles for article (PubMed ID: 9087534)
1. Intratumoral heterogeneity of S phase transition in solid tumours determined by bromodeoxyuridine labelling and flow cytometry.
Baisch H; Otto U
Cell Prolif; 1993 Sep; 26(5):439-48. PubMed ID: 9087534
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneous cell kinetics in tumors analyzed with a simulation model for bromodeoxyuridine single and multiple labeling.
Baisch H; Otto U; Hatje U; Fack H
Cytometry; 1995 Sep; 21(1):52-61. PubMed ID: 8529471
[TBL] [Abstract][Full Text] [Related]
3. A method to estimate cell cycle time and growth fraction using bromodeoxyuridine-flow cytometry data from a single sample.
Eidukevicius R; Characiejus D; Janavicius R; Kazlauskaite N; Pasukoniene V; Mauricas M; Den Otter W
BMC Cancer; 2005 Sep; 5():122. PubMed ID: 16176590
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric measurement of cell cycle kinetics in rat Walker-256 carcinoma following in vivo and in vitro pulse labelling with bromodeoxyuridine.
Fogt F; Wan J; O'Hara C; Bistrian BR; Blackburn GL; Istfan NW
Cytometry; 1991; 12(1):33-41. PubMed ID: 1825629
[TBL] [Abstract][Full Text] [Related]
5. Comparison of BrdUrd and [3H]TdR incorporation to estimate cell proliferation, cell loss, and potential doubling time in tumor xenografts.
Zätterström UK; Johansson M; Källén A; Baldetorp B; Oredsson S; Wennerberg J; Killander D
Cytometry; 1992; 13(8):872-9. PubMed ID: 1459003
[TBL] [Abstract][Full Text] [Related]
6. Abnormal DNA synthesis in polyamine deficient cells revealed by bromodeoxyuridine-flow cytometry technique.
Fredlund JO; Johansson M; Baldetorp B; Oredsson SM
Cell Prolif; 1994 May; 27(5):243-56. PubMed ID: 10465009
[TBL] [Abstract][Full Text] [Related]
7. Growth of human prostate carcinomas with and without hormone alpha- dehydrotestosterone in nude mice.
Baisch H; Otto U; Fack H
Eur Urol; 1998 Dec; 34(6):505-11. PubMed ID: 9831793
[TBL] [Abstract][Full Text] [Related]
8. Kinetic heterogeneity of an experimental tumour revealed by BrdUrd incorporation and mathematical modelling.
Bertuzzi A; Faretta M; Gandolfi A; Sinisgalli C; Starace G; Valoti G; Ubezio P
Bull Math Biol; 2002 Mar; 64(2):355-84. PubMed ID: 11926121
[TBL] [Abstract][Full Text] [Related]
9. Cell kinetic analysis of murine squamous cell carcinomas: a comparison of single versus double labelling using flow cytometry and immunohistochemistry.
Schultz-Hector S; Begg AC; Hofland I; Kummermehr J; Sund M
Br J Cancer; 1993 Dec; 68(6):1097-103. PubMed ID: 8260360
[TBL] [Abstract][Full Text] [Related]
10. Cell proliferation in human tumours growing in nude mice: renal cell carcinomas, larynx and hypopharynx carcinomas.
Maurer-Schultze B; Bassukas ID; Böswald M; Harasim M
J Cancer Res Clin Oncol; 1992; 118(4):255-68. PubMed ID: 1577846
[TBL] [Abstract][Full Text] [Related]
11. The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry.
Wilson GD; McNally NJ; Dunphy E; Kärcher H; Pfragner R
Cytometry; 1985 Nov; 6(6):641-7. PubMed ID: 4064843
[TBL] [Abstract][Full Text] [Related]
12. The applications of the BrdUrd-technique for the estimation of cycling S-phase cells in human renal cell carcinoma.
Langer EM; Hemmer J; Kleinhans G; Göhde W
Urol Res; 1988; 16(4):303-7. PubMed ID: 3176205
[TBL] [Abstract][Full Text] [Related]
13. Radiation effects on S-phase duration, labelling index, potential doubling time and DNA distribution in head and neck cancer xenografts.
Zätterström UK; Engellau J; Johansson MC; Wennerberg J; Kjellén E
Acta Oncol; 1995; 34(2):205-11. PubMed ID: 7718258
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric estimation of cell cycle parameters using a monoclonal antibody to bromodeoxyuridine.
Sasaki K; Murakami T; Ogino T; Takahashi M; Kawasaki S
Cytometry; 1986 Jul; 7(4):391-5. PubMed ID: 3089742
[TBL] [Abstract][Full Text] [Related]
15. Measurement of cell kinetics in cervical tumours using bromodeoxyuridine.
Bolger BS; Cooke TG; Symonds RP; MacLean AB; Stanton PD
Br J Cancer; 1993 Jul; 68(1):166-71. PubMed ID: 8318408
[TBL] [Abstract][Full Text] [Related]
16. Increase in the fraction of necrotic, not apoptotic, cells in SiHa xenograft tumours shortly after irradiation.
Olive PL; Vikse CM; Vanderbyl S
Radiother Oncol; 1999 Jan; 50(1):113-9. PubMed ID: 10225565
[TBL] [Abstract][Full Text] [Related]
17. A method to measure the duration of DNA synthesis and the potential doubling time from a single sample.
Begg AC; McNally NJ; Shrieve DC; Kärcher H
Cytometry; 1985 Nov; 6(6):620-6. PubMed ID: 4064842
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous triple staining for hypoxia, proliferation, and DNA content in murine tumours.
Webster L; Hodgkiss RJ; Wilson GD
Cytometry; 1995 Dec; 21(4):344-51. PubMed ID: 8608732
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of mitotic melanoma cells from G2 cells and their isolation by use of 5-bromo-2'-deoxyuridine and propidium iodide.
Trinkle LS; Swope VB; Abdel-Malek ZA; Nordlund JJ
Cytometry; 1988 Sep; 9(5):432-5. PubMed ID: 3180943
[TBL] [Abstract][Full Text] [Related]
20. Bromodeoxyuridine enhancement of 1-beta-D-arabinofuranosylcytosine metabolic activation and toxicity in HL-60 leukemic cells.
Ross DD; Joneckis CC; Song TH; Wu RK
Cancer Res; 1988 Feb; 48(3):517-21. PubMed ID: 3335018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
